Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026)

Fortrea Holdings (FTRE) reported Share-based Compensation of $11.4 million for Q1 2026, down 21.92% on a YoY basis from $14.6 million in Q1 2025, and down 22.97% quarter-over-quarter from $14.8 million in Q4 2025.

Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Share-based Compensation for 5 years, with the latest figure at $11.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 21.92% year-over-year to $11.4 million; the trailing twelve-month figure through Mar 2026 stood at $71.2 million (up 22.97% YoY), and the FY2025 full-year result was $74.4 million, up 27.4% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $11.4 million, down from $14.8 million in the prior quarter.
  • The five-year high for Share-based Compensation was $22.7 million in Q2 2025, with the low at $5.8 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $13.3 million across 5 years, with a median of $14.6 million in 2025.
  • Annual changes were most pronounced in 2023 — Share-based Compensation jumped 167.24% — and 2026, when it decreased 21.92%.
  • Fortrea Holdings' Share-based Compensation stood at $5.8 million in 2022, then jumped by 167.24% to $15.5 million in 2023, then declined by 1.29% to $15.3 million in 2024, then decreased by 3.27% to $14.8 million in 2025, then decreased by 22.97% to $11.4 million in 2026.
  • The last three Share-based Compensation figures came in at $11.4 million (Q1 2026), $14.8 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 11.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.40 Mn
Mar 31, 2026 11.40 Mn
Dec 31, 2025 14.80 Mn
Dec 31, 2025 14.80 Mn
Sep 30, 2025 22.30 Mn
Sep 30, 2025 22.30 Mn
Jun 30, 2025 22.70 Mn
Jun 30, 2025 22.70 Mn
Mar 31, 2025 14.60 Mn
Mar 31, 2025 14.60 Mn
Dec 31, 2024 15.30 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 13.00 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 15.00 Mn
Jun 30, 2024 15.00 Mn
Mar 31, 2024 15.10 Mn
Mar 31, 2024 15.10 Mn
Dec 31, 2023 15.50 Mn
Dec 31, 2023 15.50 Mn